Pikralida Pharma Servicessp. z o.o.
Other research and experimental development on natural sciences and engineering
Overview
Pikralida Pharma Services combines drug research and development with CRO services for pharmaceutical companies, carrying out clinical-stage projects. Its flagship project is PKL-021, an inhibitor of enzymes in the metalloproteinase group. The Poznań laboratory develops medicinal product formulations, while the Warsaw laboratory develops manufacturing processes for active substances.
- ul. Rydygiera 8 bud. 13, 01-793 Warszawa
Financials
Revenue history
Financial insight
- Possible Estonian CIT: Equity includes Art. 28d line items, but all amounts are 0 – this may be an accounting template or the first year of the regime.
Filing timeliness
Financial statements were filed on time, on average 5 days early.
- 202513/07/2026
- 202407/07/2025
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
News
Industry
Offer
- Chemical synthesis
- Drug formulation development
- Pharmaceutical analysis
- Analytical method validation
Website technology
- Website
- WordPress
- Elementor
Authorized Representatives
Manner of representation
In the case of a multi-member management board, the company is represented by the President of the Management Board of the company independently, or by two members of the management board of the company jointly, or by one member of the management board acting jointly with a commercial proxy.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
| 700 | $9,454.35 | 100% |
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2024-05-08.
09 1600 1462 1735 0291 4000 0001
Debt
No entries in the National Debtors Register (KRZ).
Public aid
No public aid cases recorded in the last 10 years.
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Pikralidasp. z o.o. | $1,151,165.63 | pikralida.eu | ||
| Bioresearch Groupsp. z o.o. | $776,186.19 | bioresearch.pl | ||
| Scientia Crosp. z o.o. | $607,622.19 | scientiacro.com | ||
| Pharmacy Research Institutesp. z o.o. | $294,406.08 | pharmacyinstitute.pl | ||
| Genelyticasp. z o.o. | $213,207.91 | genelytica.pl | ||
| Gcp-Service International Ltd. & Co. KgBranch (foreign co.) | $159,376.34 | gcp-service.com | ||
| Pharmaxi Polandsp. z o.o. | $152,292.34 | pharmaxi.com.ua | ||
| Chemlabsp. z o.o. | $144,354.49 | chemlab.com.pl | ||
| Neuro-Opiomelsp. z o.o. | $19,173.50 | neuroopiomel.com | ||
| Scilosp. z o.o. | $12,634.81 | scilo.eu |
Change history
| Date | Event | |
|---|---|---|
| 2026-10-27 | Share capital increase (15,000.00 PLN → 35,000.00 PLN) | |
| 2025-04-17 | Share capital increase (5,000.00 PLN → 15,000.00 PLN) | |
| 2024-03-01 | Entered in the register |
FAQ
Last updated: 2026-10-27